<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Merosin-deficient <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> type 1A (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e>) is a lethal <z:hpo ids='HP_0003202'>muscle-wasting</z:hpo> disease that is caused by mutations in the LAMA2 gene, resulting in the loss of laminin-α2 protein </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> patients exhibit severe <z:hpo ids='HP_0001324'>muscle weakness</z:hpo> from birth, are confined to a wheelchair, require ventilator assistance, and have reduced life expectancy </plain></SENT>
<SENT sid="2" pm="."><plain>There are currently no effective treatments or cures for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Laminin-α2 is required for the formation of heterotrimeric laminin-211 (ie, α2, β1, and γ1) and laminin-221 (ie, α2, β2, and γ1), which are major constituents of skeletal muscle basal lamina </plain></SENT>
<SENT sid="4" pm="."><plain>Laminin-111 (ie, α1, β1, and γ1) is the predominant laminin isoform in embryonic skeletal muscle and supports <z:mpath ids='MPATH_458'>normal</z:mpath> skeletal muscle development in laminin-α2-deficient muscle but is absent from adult skeletal muscle </plain></SENT>
<SENT sid="5" pm="."><plain>In this study, we determined whether treatment with Engelbreth-Holm-Swarm-derived mouse laminin-111 protein could rescue <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> in the dy(W-/-) mouse model </plain></SENT>
<SENT sid="6" pm="."><plain>We demonstrate that laminin-111 protein systemically delivered to the muscles of laminin-α2-deficient mice prevents muscle pathology, improves muscle strength, and dramatically increases life expectancy </plain></SENT>
<SENT sid="7" pm="."><plain>Laminin-111 also prevented <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in laminin-α2-deficient mouse muscle and primary human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> myogenic cells, which indicates a conserved mechanism of action and cross-reactivity between species </plain></SENT>
<SENT sid="8" pm="."><plain>Our results demonstrate that laminin-111 can serve as an effective protein substitution therapy for the treatment of <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> in the dy(W-/-) mouse model and establish the potential for its use in the treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDC1A</z:e> </plain></SENT>
</text></document>